Correlation Between Aravive and Madrigal Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Aravive and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aravive and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aravive and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Aravive and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aravive with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aravive and Madrigal Pharmaceuticals.
Diversification Opportunities for Aravive and Madrigal Pharmaceuticals
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Aravive and Madrigal is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Aravive and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Aravive is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aravive are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Aravive i.e., Aravive and Madrigal Pharmaceuticals go up and down completely randomly.
Pair Corralation between Aravive and Madrigal Pharmaceuticals
Given the investment horizon of 90 days Aravive is expected to under-perform the Madrigal Pharmaceuticals. In addition to that, Aravive is 1.22 times more volatile than Madrigal Pharmaceuticals. It trades about -0.83 of its total potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.05 per unit of volatility. If you would invest 21,318 in Madrigal Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 9,959 from holding Madrigal Pharmaceuticals or generate 46.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 1.14% |
| Values | Daily Returns |
Aravive vs. Madrigal Pharmaceuticals
Performance |
| Timeline |
| Aravive |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Madrigal Pharmaceuticals |
Aravive and Madrigal Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aravive and Madrigal Pharmaceuticals
The main advantage of trading using opposite Aravive and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aravive position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.The idea behind Aravive and Madrigal Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |